AnGes To Conduct Additional Trial For HGF Plasmid, Aims NDA In Japan, U.S. And Europe
This article was originally published in PharmAsia News
Executive Summary
AnGes MG plans to start an additional trial and submit a new drug application for HGF plasmid Collategene (beperminogene) in Japan, Europe and the U.S